Printer Friendly
The Free Library
14,458,801 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: Analyse Product Catalogues and Pipelines at Interleukin Genetics Inc.


DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c48505) has announced the addition of Interleukin interleukin

Any of a class of naturally occurring proteins important in regulation of lymphocyte function. Several known types are recognized as crucial constituents of the body's immune system (see immunity).
 Genetics Inc. - Competitor Report to their offering.

The Interleukin Genetics Inc. Competitor Report includes a business summary, tabular tab·u·lar
adj.
1. Having a plane surface; flat.

2. Organized as a table or list.

3. Calculated by means of a table.



tabular

resembling a table.
 representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil dis·till also dis·til  
v. dis·tilled also dis·tilled, dis·till·ing also dis·til·ling, dis·tills also dis·tils

v.tr.
1. To subject (a substance) to distillation.

2.
 and systematize sys·tem·a·tize  
tr.v. sys·tem·a·tized, sys·tem·a·tiz·ing, sys·tem·a·tiz·es
To formulate into or reduce to a system: "The aim of science is surely to amass and systematize knowledge" 
 pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The Interleukin Genetics Inc Competitor report therefore delivers the latest and the most comprehensive intelligence available on the key companies active within Interleukin Genetics Inc's. markets.

Competitor

Business Summary

Contact Information

Selected Financial Data

Company Details

Product Glance (Table/Graph)

Disease Hub Classification (Table/Graph)

Product Pipeline

Products

Competitor Details by Therapeutic Indication

Recent Updates

Sample Screenshot See screen shot.  

For more information visit http://www.researchandmarkets.com/reports/c48505
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 16, 2007
Words:212
Previous Article:Research and Markets : New Report Profiles Competitors of InSite Vision Incorporated.
Next Article:Research and Markets: Gain Valuable Information on Inovio Biomedical Corp's Many Competitors.
Topics:



Related Articles
Interleukin Genetics Reports First Quarter Financial Results.
Interleukin Genetics Initiates Study of IL-1 Variations and Incidence of Early Stroke in Italian Population; Collaboration with Catholic University...
Interleukin Genetics Reports Second Quarter Financial Results; Conference Call Scheduled for 8:30 AM EDT - August 10, 2006.
Interleukin Genetics Acquires Alan James Group and Secures $30 Million in New Financing; Combination Creates Fully Integrated Personalized Healthcare...
Interleukin Genetics Initiates Study of IL-1 Gene Variation and Osteoporosis in Korean Women; Collaboration with Yonsei University to Analyze IL-1...
Interleukin Genetics Reports Third Quarter Financial Results.
Interleukin Genetics Sponsors Expert Meeting on the Role of Inflammation in Aging.
ACC Presentation Indicates Interleukin-1 Gene Variants Determine Increased Risk for Coronary Artery Disease from Oxidized Phospholipids.
Interleukin Genetics Reports 2006 Year-End and Fourth Quarter Financial Results.(Financial report)
Interleukin Genetics Expands Research Collaboration with Alticor.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles